LineaRx Provides Cost and Quality Advantages to Technogenetics
November 7th, 2018
LineaRx Provides Cost and Quality Advantages to Technogenetics
November 7th, 2018
New Study: DNA Molecular Tagging is an Effective Tool to Authenticate Denim
November 5th, 2018
“CIRKULARITY” Inspired By “REKOOP” Sustainable, Traceable, rPET Bedding
October 29th, 2018
Applied DNA Enters FY2019 with Strong Business Momentum
October 24th, 2018
Applied DNA Subsidiary LineaRx Licenses CAR T Drug Candidate and Initiates Pre-Clinical Development of Non-viral, Plasmid-free CAR T Manufacturing Platform
October 16th, 2018
APDN Appoints Wayne Buchen VP of Strategic Sales for Textile Vertical
October 4th, 2018
LineaRx Secures New RNA Therapeutics Customers for Contract Research Services
October 1st, 2018
Applied DNA Expands Its Cannabis Tagging Portfolio to Address Large Growers
September 25th, 2018
Applied DNA Subsidiary, LineaRx, Inc. Signs Joint Development Agreement with Takis and Evvivax to Develop Linear-DNA Based Anti-Cancer Vaccines
September 20th, 2018

Our new ticker symbol is ‘BNBX’. Learn more here.